Virax Biolabs Group Limited — Cash Flow (NASDAQ:VRAX) | MetaTrader

Open full chart

Financials

Overview Relevé Statistics Dividends

Quarterly Annual

Cash from operating activities -809.07 K-4.18 M-6.25 M-4.56 M — Cash from investing activities —-178.4 K-1.16 M-603.89 K — Cash from financing activities 813.2 K13.69 M1.65 M5.81 M — Free cash flow -809.07 K-4.18 M-6.25 M-4.56 M —

Nouvelles

Virax Biolabs Group Limited (VRAX) Upgraded to Buy: Here's Why

L’objectif de prix de l’action Virax Biolabs abaissé à 1$ par H.C. Wainwright

Virax Biolabs stock price target lowered to $1 at H.C. Wainwright

Pourquoi les actions UiPath se négocient-elles plus haut d'environ 9 % ; Voici 20 actions qui bougent avant l'ouverture du marché | Benzinga France

Virax Biolabs (VRAX) : Les actions se refroidissent après les heures de négociation suite à une hausse de 75% | Benzinga France

Why UiPath Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket - Axogen (NASDAQ:AXGN), Addex Therapeutics (NASDAQ:ADXN)

Virax Biolabs (VRAX) Stock Cools After Hours Following 75% Rally - Virax Biolabs Group (NASDAQ:VRAX)

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.86%

L’action de Virax Biolabs s’envole après des progrès cliniques dans les diagnostics post-infection

Virax Biolabs stock rockets after clinical progress in post-infection diagnostics

Crude Oil Gains 1%; Macy's Reports Strong Q3 Results - Aeva Technologies (NASDAQ:AEVA), ADC Therapeutics (NYSE:ADCT)

US Stocks Mixed; Dollar Tree Posts Upbeat Earnings - Black Diamond Therapeutic (NASDAQ:BDTX), Capricor Therapeutics (NASDAQ:CAPR)